A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1, 2, 4, 5 or 6 Infection and Compensated Cirrhosis
PHASE3CompletedINTERVENTIONAL
Enrollment
146
Participants
Timeline
Start Date
December 7, 2015
Primary Completion Date
October 27, 2016
Study Completion Date
February 10, 2017
Conditions
Hepatitis C Virus InfectionChronic Hepatitis CCompensated Cirrhosis